Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,265
datasets available to search
ShareScore release 0.9.0
Dataset results
1,265 results for “ATOPIC DERMATITIS”
Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT05641558. IPD Sharing: NO. Countries: 1. Publications: 0.
Eczema Action Plan Improves Patient and Caregiver Understanding and Perception of Atopic Dermatitis Management
ClinicalTrials.gov study NCT01660217. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic Dermatitis
ClinicalTrials.gov study NCT06998056. IPD Sharing: UNDECIDED. Countries: 3. Publications: 0.
Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis
ClinicalTrials.gov study NCT00376129. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis
ClinicalTrials.gov study NCT00460083. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland
ClinicalTrials.gov study NCT05819463. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation
ClinicalTrials.gov study NCT05098821. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis
ClinicalTrials.gov study NCT05571943. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT05158023. IPD Sharing: NO. Countries: 8. Publications: 0.
A Trial of Antroquinonol in Patients With Atopic Dermatitis
ClinicalTrials.gov study NCT03622463. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
ClinicalTrials.gov study NCT02465606. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT06526182. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden
ClinicalTrials.gov study NCT07006792. IPD Sharing: YES. Countries: 5. Publications: 0.
A Study to Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic Dermatitis
ClinicalTrials.gov study NCT03304470. IPD Sharing: NO. Countries: 1. Publications: 0.
Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4
ClinicalTrials.gov study NCT03556592. IPD Sharing: NO. Countries: 3. Publications: 0.
Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis
ClinicalTrials.gov study NCT06468956. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis
ClinicalTrials.gov study NCT07321951. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
The Effect of Nature-based Exposure on the Immune System and Skin Health of Atopic Dermatitis Patients.
ClinicalTrials.gov study NCT06129136. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis
ClinicalTrials.gov study NCT04725136. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)
ClinicalTrials.gov study NCT01359787. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.